Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
D000818:Animals; D001215:Asparaginase / Q000008:administration & dosage / Q000627:therapeutic use*; D001380:Azauridine / Q000008:administration & dosage / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D004357:Drug Synergism; D005260:Female; D007939:Leukemia L1210 / Q000188:drug therapy*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D009368:Neoplasm Transplantation; D014184:Transplantation, Homologous
D003561:Cytarabine; D001380:Azauridine; D001215:Asparaginase